Literature DB >> 8642298

Tumor necrosis factor alpha and interleukin 1beta are responsible for in vitro myocardial cell depression induced by human septic shock serum.

A Kumar1, V Thota, L Dee, J Olson, E Uretz, J E Parrillo.   

Abstract

Previous studies have demonstrated the presence of myocardial depression in clinical and experimental septic shock. This depression is associated with the presence of a circulating myocardial depressant substance with physical characteristics consistent with cytokines. The present study utilized an in vitro myocardial cell assay to examine the role of various human recombinant cytokines, including tumor necrosis factor (TNF)alpha and interleukin (IL)1beta, in depression of cardiac myocyte contractile function induced by serum from humans with septic shock. The extent and velocity of electrically paced rat cardiac myocytes in tissue culture was quantified by a closed loop video tracking system. Individually, TNF-alpha and IL-1beta each caused significant concentration-dependent depression of maximum extent and peak velocity of myocyte shortening in vitro. In combination, TNF-alpha and IL-1beta induced depression of myocardial cell contractility at substantially lower concentrations consistent with a synergistic effect. Using immunoabsorption, removal of both TNF-alpha and IL-1beta (but not either alone) from the serum of five patients with acute septic shock and marked reversible myocardial depression resulted in elimination of serum myocardial depressant activity. IL-2, -4, -6, -8, -10, and interferon gamma failed to cause significant cardiac myocyte depression over a wide range of concentrations. These data demonstrate that TNF-alpha and IL-1beta cause depression of myocardial cell contraction in vitro and suggest that these two cytokines act synergistically to cause sepsis-associated myocardial depression in humans.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8642298      PMCID: PMC2192364          DOI: 10.1084/jem.183.3.949

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  41 in total

1.  Immediate release of a nitric oxide-like factor from bovine aortic endothelial cells by Escherichia coli lipopolysaccharide.

Authors:  D Salvemini; R Korbut; E Anggård; J Vane
Journal:  Proc Natl Acad Sci U S A       Date:  1990-04       Impact factor: 11.205

2.  Mechanism of cytokine inhibition of beta-adrenergic agonist stimulation of cyclic AMP in rat cardiac myocytes. Impairment of signal transduction.

Authors:  M K Chung; T S Gulick; R E Rotondo; G F Schreiner; L G Lange
Journal:  Circ Res       Date:  1990-09       Impact factor: 17.367

3.  Interleukin 1 and tumor necrosis factor inhibit cardiac myocyte beta-adrenergic responsiveness.

Authors:  T Gulick; M K Chung; S J Pieper; L G Lange; G F Schreiner
Journal:  Proc Natl Acad Sci U S A       Date:  1989-09       Impact factor: 11.205

Review 4.  Septic shock in humans. Advances in the understanding of pathogenesis, cardiovascular dysfunction, and therapy.

Authors:  J E Parrillo; M M Parker; C Natanson; A F Suffredini; R L Danner; R E Cunnion; F P Ognibene
Journal:  Ann Intern Med       Date:  1990-08-01       Impact factor: 25.391

5.  A circulating myocardial depressant substance is associated with cardiac dysfunction and peripheral hypoperfusion (lactic acidemia) in patients with septic shock.

Authors:  J M Reilly; R E Cunnion; C Burch-Whitman; M M Parker; J H Shelhamer; J E Parrillo
Journal:  Chest       Date:  1989-05       Impact factor: 9.410

6.  Right ventricular dysfunction and dilatation, similar to left ventricular changes, characterize the cardiac depression of septic shock in humans.

Authors:  M M Parker; K E McCarthy; F P Ognibene; J E Parrillo
Journal:  Chest       Date:  1990-01       Impact factor: 9.410

7.  Interleukin 1 induces a shock-like state in rabbits. Synergism with tumor necrosis factor and the effect of cyclooxygenase inhibition.

Authors:  S Okusawa; J A Gelfand; T Ikejima; R J Connolly; C A Dinarello
Journal:  J Clin Invest       Date:  1988-04       Impact factor: 14.808

8.  The complex pattern of cytokines in serum from patients with meningococcal septic shock. Association between interleukin 6, interleukin 1, and fatal outcome.

Authors:  A Waage; P Brandtzaeg; A Halstensen; P Kierulf; T Espevik
Journal:  J Exp Med       Date:  1989-01-01       Impact factor: 14.307

9.  Interleukin 1 potentiates the lethal effect of tumor necrosis factor alpha/cachectin in mice.

Authors:  A Waage; T Espevik
Journal:  J Exp Med       Date:  1988-06-01       Impact factor: 14.307

10.  Endotoxin and tumor necrosis factor challenges in dogs simulate the cardiovascular profile of human septic shock.

Authors:  C Natanson; P W Eichenholz; R L Danner; P Q Eichacker; W D Hoffman; G C Kuo; S M Banks; T J MacVittie; J E Parrillo
Journal:  J Exp Med       Date:  1989-03-01       Impact factor: 14.307

View more
  180 in total

1.  Cardiovascular Dysfunction in Sepsis and Septic Shock.

Authors: 
Journal:  Curr Treat Options Cardiovasc Med       Date:  2000-10

Review 2.  Pathophysiology of meningococcal meningitis and septicaemia.

Authors:  N Pathan; S N Faust; M Levin
Journal:  Arch Dis Child       Date:  2003-07       Impact factor: 3.791

3.  Hypoxia-inducible factor 2alpha regulates macrophage function in mouse models of acute and tumor inflammation.

Authors:  Hongxia Z Imtiyaz; Emily P Williams; Michele M Hickey; Shetal A Patel; Amy C Durham; Li-Jun Yuan; Rachel Hammond; Phyllis A Gimotty; Brian Keith; M Celeste Simon
Journal:  J Clin Invest       Date:  2010-07-19       Impact factor: 14.808

4.  Overexpression of interleukin-18 aggravates cardiac fibrosis and diastolic dysfunction in fructose-fed rats.

Authors:  Shan-Shan Xing; Xiu-Ping Bi; Hong-Wei Tan; Yun Zhang; Qi-Chong Xing; Wei Zhang
Journal:  Mol Med       Date:  2010-07-12       Impact factor: 6.354

5.  Minocycline reverses IL-17A/TRAF3IP2-mediated p38 MAPK/NF-κB/iNOS/NO-dependent cardiomyocyte contractile depression and death.

Authors:  Tadashi Yoshida; Nitin A Das; Andrea J Carpenter; Reza Izadpanah; Senthil A Kumar; Sandeep Gautam; Shawn B Bender; Ulrich Siebenlist; Bysani Chandrasekar
Journal:  Cell Signal       Date:  2020-06-15       Impact factor: 4.315

6.  Septic shock: a heart story since the 1960s.

Authors:  C Rabuel; A Mebazaa
Journal:  Intensive Care Med       Date:  2006-03-29       Impact factor: 17.440

7.  The multiple organ dysfunction syndrome and late-phase mortality in sepsis.

Authors:  Joshua A Englert; Mitchell P Fink
Journal:  Curr Infect Dis Rep       Date:  2005-09       Impact factor: 3.725

Review 8.  Role of Inflammation in Heart Failure.

Authors:  Lily F Shirazi; Joe Bissett; Francesco Romeo; Jawahar L Mehta
Journal:  Curr Atheroscler Rep       Date:  2017-06       Impact factor: 5.113

Review 9.  Modulating LPS signal transduction at the LPS receptor complex with synthetic Lipid A analogues.

Authors:  Aileen F B White; Alexei V Demchenko
Journal:  Adv Carbohydr Chem Biochem       Date:  2014       Impact factor: 12.200

10.  IL-1 Blockade in Patients With Heart Failure With Preserved Ejection Fraction.

Authors:  Benjamin W Van Tassell; Cory R Trankle; Justin M Canada; Salvatore Carbone; Leo Buckley; Dinesh Kadariya; Marco G Del Buono; Hayley Billingsley; George Wohlford; Michele Viscusi; Claudia Oddi-Erdle; Nayef A Abouzaki; Dave Dixon; Giuseppe Biondi-Zoccai; Ross Arena; Antonio Abbate
Journal:  Circ Heart Fail       Date:  2018-08       Impact factor: 8.790

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.